Steward Partners Investment Advisory’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-527
Closed -$632 4027
2024
Q4
$632 Sell
527
-400
-43% -$664 ﹤0.01% 3823
2024
Q3
$1.58K Sell
927
-10
-1% -$15 ﹤0.01% 3470
2024
Q2
$1.1K Buy
937
+527
+129% +$550 ﹤0.01% 3381
2024
Q1
$406 Hold
410
﹤0.01% 3442
2023
Q4
$1.61K Hold
410
﹤0.01% 3243
2023
Q3
$2.36K Hold
410
﹤0.01% 3052
2023
Q2
$3.32K Hold
410
﹤0.01% 2920
2023
Q1
$2.87K Hold
410
﹤0.01% 2947
2022
Q4
$2.9K Buy
410
+375
+1,071% +$4.09K ﹤0.01% 2936
2022
Q3
$1K Hold
35
﹤0.01% 3100
2022
Q2
$0 Hold
35
﹤0.01% 3239
2022
Q1
$1K Hold
35
﹤0.01% 3158
2021
Q4
$2K Sell
35
-10
-22% -$557 ﹤0.01% 3001
2021
Q3
$3K Sell
45
-5
-10% -$326 ﹤0.01% 2908
2021
Q2
$4K Hold
50
﹤0.01% 6672
2021
Q1
$4.16K Hold
50
﹤0.01% 3057
2020
Q4
$4K Hold
50
﹤0.01% 2547
2020
Q3
$5K Hold
50
﹤0.01% 2348
2020
Q2
$8K Hold
50
﹤0.01% 2109
2020
Q1
$4K Hold
50
﹤0.01% 2124
2019
Q4
$8K Hold
50
﹤0.01% 2081
2019
Q3
$9K Hold
50
﹤0.01% 2020
2019
Q2
$11K Buy
+50
New +$9.78K ﹤0.01% 1921
2018
Q4
Sell
-50
Closed -$11K 878
2018
Q3
$11K Hold
50
﹤0.01% 1823
2018
Q2
$11K Buy
+50
New +$11.2K ﹤0.01% 1691

Other funds holding AXDX

Steward Partners Investment Advisory's AXDX Position: Q1 2025 in Review

Steward Partners Investment Advisory sold out of Accelerate Diagnostics (AXDX) in Q1 2025, closing a stake of 527 shares — an estimated $632 sold.

Steward Partners Investment Advisory first reported a position in AXDX in Q2 2018 and held it in 25 quarters. The position peaked at $11K in Q2 2019. 43 funds tracked by Wall St. Rank hold AXDX as of Q1 2025.

  • Steward Partners Investment Advisory reported no remaining Accelerate Diagnostics position as of Q1 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 527 Accelerate Diagnostics shares in Q1 2025, an estimated $632.
  • Steward Partners Investment Advisory first reported a position in Accelerate Diagnostics in Q2 2018 and held it in 25 quarters.
  • Steward Partners Investment Advisory's Accelerate Diagnostics position peaked at $11K in Q2 2019.
  • 43 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2025, filed 13 May 2025.